ConforMIS, founded in 2004 and based in Bedford, Massachusetts, USA, creates personalised, patient-specific implants and disposable instrumentation utilising proprietary imaging technology. The company produces knee systems under the iUni, iDuo and iTotal brands. Each one has received FDA 510(k) clearance and carries the CE, supporting the multi-regional commercial approach.
ConforMIS launched its next-generation, patient-specific total knee replacement implant system in October 2012. It’s the only patient-specific system available on the market. Because of its unique attributes, interest in iTotal has been brisk.
The company’s products are currently being sold in US and Europe.
Founder, Chief Executive Officer, President and Chairman, Dr. Philipp Lang, is a trained radiologist with extensive experience in the medtech industry. As an inventor of more than 80 pending and issued patents in the US and abroad, he is a respected thought leader in the industry. Dr. Lang oversees ConforMIS’ worldwide strategy and business development. In addition, he works closely with strategic partners.
John Slamin, Senior Vice President of Knee Implant Engineering, is responsible for product engineering and development for all of ConforMIS’ knee implants. Before ConforMIS, he spent 30 years in research and development at Depuy, Johnson & Johnson’s orthopaedic division. He is the holder of seven patents related to knee implant engineering.